Rapid Diagnostic Test for Candida Can Cut Time to Initiation of Therapy

October 18, 2017 | Risk Management News

Preview

​Use of the T2Candida (T2C) rapid diagnostic test for Candidainfections can significantly decrease time to initiation of therapy and may help optimize antifungal therapy, according to a study published October 7, 2017, in a poster at the ID Week 2017 meeting in San Diego, California.

Access Full Content

Contact us today at 610.825.6000.